It's possible but it sort of needs to work even with co-morbidities... The trial is for ARDS patients <3 days on a ventilator. So the quite ill but not yet absolutely critical. If it's efficacous even for a decent percentage (and not harmful to many / any) it can be approved.
The FDA and Meosblast could always do a Phase 4 study afterwards
Phase 4: Studies occurring after FDA has approved a drug for marketing. These including postmarket requirement and commitment studies that are required of or agreed to by the sponsor. These studies gather additional information about a drug's safety, efficacy, or optimal use.
Gilead vs Mesoblast, page-274
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.010(0.90%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.11 | $2.243M | 1.984M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 79256 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 18507 | 6 |
View Market Depth
| Last trade - 10.33am 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |